分子靶向药物在妇科肿瘤治疗中的应用(6)
[20] du Bois A, Floquet A, Kim JW, et al. Incorporation of pazopanib in maintenance therapy of ovarian cancer [J]. J Clin Oncol, 2014, 32(30): 3374-3382.[21] Schmidt C. Cediranib aims for a comeback [EB/OL]. [2015-04-21]. http://jnci.oxfordjournals.org/content/107/3/djv068. full.pdf+html.
[22] Raja FA, Perren TJ, Embleton A, et al. Randomised doubleblind phase III trail of cediranib (AZD 2171) in relapsed platinum sensitive ovarian cancer: results of the ICON6 trail[J]. Int J Gynecol Cancer ......
您现在查看是摘要页,全文长 3108 字符。